ARCALYST® (rilonacept) 2025 net product revenue of $677.5 million (unaudited), representing ~62% year-over-year growth –– ...
The centre-left's defensive crouch has made it look like a guardian of an unfair status quo—radical reformism offers escape.
ARCALYST- (rilonacept) 2025 net product revenue of $677.5 million (unaudited), representing ~62% year-over-year growth -- ARCALYST 2026 net product revenue expected to be $900 - $920 million -- KPL-38 ...
New Drug Application (NDA) for NonAdvSM submitted in December 2025, NDA submission for AdvSM on track for 1H 2026NDA submission for GIST on track for April 2026; bezuclastinib has the potential to be ...
Astroyogi on MSN
Leo daily, weekly and monthly horoscope
Daily Horoscope Dear Leo, because the Moon is still in Libra today, you may be in a good mood. You may not want to ...
Reading Eagle on MSN
Bulletin board: Arts center in Reading launches Game Night
The WCR Center for the Arts, 140 N. Fifth St., Reading, is launching Game Night, a monthly community gathering. The event ...
CENTENNIAL, CO / ACCESS Newswire / January 12, 2026 / NioCorp Developments Ltd. ("NioCorp," "our," or the "Company") (NASDAQ:NB) today provided its preliminary unaudited financial results for the ...
Wave expects to initiate a Phase 2a multidose portion of WVE-007 INLIGHT clinical trial in individuals living with obesity ...
Kinetik Holdings looks undervalued near its 52-week low with an 8.5% dividend yield and growth catalysts. Click here to read ...
New Drug Application (NDA) for NonAdvSM submitted in December 2025, NDA submission for AdvSM on track for 1H 2026NDA submission for GIST on track ...
Members of the Cedaredge Rotary Club heard a presentation Tuesday on the history and current practices of forest management ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback